Advertisement

Expedeon 2view™

Share:

2view™

Innovative and unique detection method for Western blot 
Expedeon’s 2view™ is an innovative and unique double labeled secondary antibody that enables extended detection within Western blotting. The product consists of a unique ternary complex developed using our world leading InnovaCoat® and Lightning-Link® conjugation technology. 2view™ secondary antibodies are labeled simultaneously with InnovaCoat® GOLD nanoparticles and horseradish peroxidase (HRP). The gold nanoparticles enable fast visible detection at nanogram level whereas the chemi- luminescent enzymatic detection enhances sensitivity down to picogram levels of protein. 
 
Expedeon’s 2view™ is available for anti-rabbit, anti-mouse and anti-goat primary antibodies.

Features

Offers two modes of detection from a single antibody 
Provides highly sensitive chemi-luminescence analysis 
Easy to use with a single incubation 
Fast visible detection 
Dual level of sensitivity (nanogram and picogram level) 
High signal-to-noise ratio 
 
There are two levels of detection: 
1st level of detection – 40nm InnovaCoat® GOLD 
 
2nd level of detection – HRP (ECL Pico)

Photos

Manuals and Resources

Note: We appreciate the support of individuals and companies making their documents and resources available to our community. If you find a document or resource that does not belong please let us know by emailing info@labwrench.com

Picture of Expedeon 2view™
Expedeon is a world-leading expert in cutting-edge innovative reagents and services for life sciences and diagnostics, with application across workflows...

More about Expedeon

Visit Expedeon

Questions and Answers

Recent Question Activity

Be the first to Ask a Question

Reviews

Member Reviews

There are no threads in Expedeon 2view™ Reviews at this time.
Add a Review

Expedeon 2view™ Articles

Helpful Resources, Articles, and Information

SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), today announced the introduction of 2view™, a unique detection method...

See All Related Articles
Advertisement